SARS-COV-2

You have access
Combination of the CD8⁺:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 Patients
MARIA G. DETSIKA, EIRINI GRIGORIOU, KATHERINA PSARRA, EDISON JAHAJ, STAMATIOS TSIPILIS, NIKOLAOS ATHANASSIOU, ALEXANDROS ZACHARIS, IOANNA DIMOPOULOU, STYLIANOS E. ORFANOS, ALEXANDRA TSIROGIANNI and ANASTASIA KOTANIDOU

In Vivo November 2021, 35 (6) 3305-3313; DOI: https://doi.org/10.21873/invivo.12626
You have access
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN and ELENA LAURA ILIESCU

In Vivo November 2021, 35 (6) 3377-3383; DOI: https://doi.org/10.21873/invivo.12636
You have access
Nine Cases of SARS-CoV-2-PCR-positive Samples Showed No Increase of Antibodies Against SARS-CoV-2
TAKAO KITAGAWA, MASANOBU KOBAYASHI, TOHRU OHTA, MASARU TERASAKI, YOKO TSUKAMOTO, RIE TAKAI, REIKA ISHIZUMI, OSAMU UEHARA, KOJI NAKAGAWA, KOZO AKINO, MASAHIRO ASAKA and YASUHIRO KURAMITSU

In Vivo September 2021, 35 (5) 2947-2949; DOI: https://doi.org/10.21873/invivo.12587
You have access
On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans?
BERND KAINA

In Vivo May 2021, 35 (3) 1313-1326; DOI: https://doi.org/10.21873/invivo.12384
You have access
Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence
ISAO SUZAKI and HITOME KOBAYASHI

In Vivo May 2021, 35 (3) 1409-1417; DOI: https://doi.org/10.21873/invivo.12393
You have access
The Experience of Greece as a Model to Contain COVID-19 Infection Spread
GEORGE J. DELINASIOS, PARASKEVI C. FRAGKOU, ATHINA M. GKIRMPA, GEORGE TSANGARIS, ROBERT M. HOFFMAN and ATHANASIOS K. ANAGNOSTOPOULOS

In Vivo March 2021, 35 (2) 1285-1294; DOI: https://doi.org/10.21873/invivo.12380
You have access
A Nasopharyngeal Carcinoma Patient With COVID-19 Infection After Immunotherapy: A Case Report and Literature Review
MENGLAN ZHAI and SHENG ZHANG

In Vivo November 2020, 34 (6) 3753-3756; DOI: https://doi.org/10.21873/invivo.12225
You have access
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality
KAREL SMETANA, DANIEL ROSEL and JAN BRÁBEK

In Vivo September 2020, 34 (5) 3027-3028; DOI: https://doi.org/10.21873/invivo.12135
You have access
Effect of Lockdown in Surgical Emergency Accesses: Experience of a COVID-19 Hospital
GIANLUCA VANNI, JACOPO MARIA LEGRAMANTE, MARCO PELLICCIARO, GERARDO DE CAROLIS, MARIA COTESTA, MARCO MATERAZZO, CHIARA BUONOMO, ANDREA FARINACCIO, FRANCESCA SANTORI, FEDERICA SARACENO, BENEDETTO IELPO, FRANCESCO AIELLO, CARLA PAGANELLI, MICHELE GRANDE, GIROLAMO DE ANDREIS, MARCELLO CHIOCCHI, LEONARDO PALOMBI and ORESTE CLAUDIO BUONOMO

In Vivo September 2020, 34 (5) 3033-3038; DOI: https://doi.org/10.21873/invivo.12137
You have access
Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece
PARASKEVI C. FRAGKOU, VASSILIKI PAPAEVANGELOU, ANASTASIA ANTONIADOU, DIMITRA KAVVATHA, AGAPI PLOUSSI, NIKOS PANTAZIS, TAMTA SIRMPILANTZE, CHRISTOS PSARRAKIS, SPYRIDON A. POURNARAS, SOTIRIOS TSIODRAS and ALEXIS KELEKIS

In Vivo September 2020, 34 (5) 3039-3045; DOI: https://doi.org/10.21873/invivo.12138

Main menu

User menu

Search

SARS-COV-2

Pages